A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
A phase 1/2 trial of Monalizumab, Durvalumab, Cetuximab, FOLFOX (5-FU, leucovorin, oxaliplatin) and Bevacizumab in advanced solid tumours, run by MedImmune LLC, active and no longer recruiting.
Overview
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors is a phase 1/2 interventional study registered as NCT02671435 by MedImmune LLC, with 383 participants enrolled, started 2016-02-22 and due to reach its primary completion in 2021-10-26. Interventions recorded: Monalizumab, Durvalumab, Cetuximab, mFOLFOX6 and Bevacizumab. Results have been posted on the registry.
Similar pages
not linked directly; found by shared links- TrialSafety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
Shares Durvalumab, AstraZeneca, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialStudy of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer
Shares Durvalumab, AstraZeneca, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialSavolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
Shares Durvalumab, AstraZeneca, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
Shares Cetuximab, Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
Shares Durvalumab, AstraZeneca and the tag pipeline.
- TrialDurvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.
Shares Durvalumab, AstraZeneca and the tag pipeline.
- TrialDurvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation
Shares Durvalumab, AstraZeneca and the tag pipeline.
- TrialA Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
Shares Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.